CLIP-seq—动物miRNA靶基因筛选新方法

2014-01-10 MedSci MedSci原创

CLIP-seq,即紫外交联免疫沉淀结合高通量测序(crosslinking-immunprecipitation and high-throughput sequencing),是一项在全基因组水平揭示RNA分子与RNA结合蛋白相互作用的革命性技术。其主要原理是基于RNA分子与RNA结合蛋白在紫外 照射下发生耦联,以RNA结合蛋白的特异性抗体将RNA-蛋白质复合体沉淀之后,回收其中的RNA

CLIP-seq,即紫外交联免疫沉淀结合高通量测序(crosslinking-immunprecipitation and high-throughput sequencing),是一项在全基因组水平揭示RNA分子与RNA结合蛋白相互作用的革命性技术。其主要原理是基于RNA分子与RNA结合蛋白在紫外 照射下发生耦联,以RNA结合蛋白的特异性抗体将RNA-蛋白质复合体沉淀之后,回收其中的RNA片段,经添加接头、RT-PCR等步骤,对这些分子进行 高通量测序,再经生物信息学的分析和处理、总结,挖掘出其特定规律,从而深入揭示RNA结合蛋白与RNA分子的调控作用及其对生命的意义。

CLIP-seq技术由于可以高通量的研究蛋白在体内与RNA的结合情况,极大的促进了蛋白质-RNA相互作用的研究。最近,这项技术也被应用到microRNA靶标鉴定等工作中。

在动物体内,成熟的单链miRNA与一系列蛋白形成miRNA诱导的沉默复合物(RISC),结合于靶mRNA的3ˊ-UTR区,阻止所结合的mRNA 的翻译或直接降解靶miRNA。基于这一原理,我们可以通过CLIP-seq技术来进行miRNA靶基因的筛选。

CLIP-Seq方法的应用能够非常明显地降低miRNA结合位点的假阳性预测频率并且减小miRNA结合位点搜寻空间的范围。可以在全基因组范围内鉴定AGO2蛋白在不同RNA上的结合位点。

锐博生物拥有最新的高通量测序平台、生物芯片制备及检测平台以及寡核苷酸生产平台,可以为大家提供CLIP-seq,miRNA测序,RNA测序,miRNA芯片,mRNA芯片等一系列服务。

 

图1 CLIP-seq原理

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=38791, encodeId=6cf438e915a, content=建议添加表观遗传学的视频,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23991655772, createdName=才华华, createdTime=Mon Oct 12 21:08:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903053, encodeId=48841903053e5, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Sep 01 22:42:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930388, encodeId=88151930388e0, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Aug 26 01:42:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312259, encodeId=73a0131225932, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1313174, encodeId=51a113131e40f, content=<a href='/topic/show?id=64dd9996046' target=_blank style='color:#2F92EE;'>#靶基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99960, encryptionId=64dd9996046, topicName=靶基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584332, encodeId=5cfa15843320c, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=)]
    2015-10-12 才华华

    建议添加表观遗传学的视频,谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=38791, encodeId=6cf438e915a, content=建议添加表观遗传学的视频,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23991655772, createdName=才华华, createdTime=Mon Oct 12 21:08:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903053, encodeId=48841903053e5, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Sep 01 22:42:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930388, encodeId=88151930388e0, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Aug 26 01:42:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312259, encodeId=73a0131225932, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1313174, encodeId=51a113131e40f, content=<a href='/topic/show?id=64dd9996046' target=_blank style='color:#2F92EE;'>#靶基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99960, encryptionId=64dd9996046, topicName=靶基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584332, encodeId=5cfa15843320c, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=38791, encodeId=6cf438e915a, content=建议添加表观遗传学的视频,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23991655772, createdName=才华华, createdTime=Mon Oct 12 21:08:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903053, encodeId=48841903053e5, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Sep 01 22:42:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930388, encodeId=88151930388e0, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Aug 26 01:42:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312259, encodeId=73a0131225932, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1313174, encodeId=51a113131e40f, content=<a href='/topic/show?id=64dd9996046' target=_blank style='color:#2F92EE;'>#靶基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99960, encryptionId=64dd9996046, topicName=靶基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584332, encodeId=5cfa15843320c, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=)]
    2014-08-26 smallant2002
  4. [GetPortalCommentsPageByObjectIdResponse(id=38791, encodeId=6cf438e915a, content=建议添加表观遗传学的视频,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23991655772, createdName=才华华, createdTime=Mon Oct 12 21:08:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903053, encodeId=48841903053e5, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Sep 01 22:42:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930388, encodeId=88151930388e0, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Aug 26 01:42:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312259, encodeId=73a0131225932, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1313174, encodeId=51a113131e40f, content=<a href='/topic/show?id=64dd9996046' target=_blank style='color:#2F92EE;'>#靶基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99960, encryptionId=64dd9996046, topicName=靶基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584332, encodeId=5cfa15843320c, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=)]
    2014-01-12 Homburg
  5. [GetPortalCommentsPageByObjectIdResponse(id=38791, encodeId=6cf438e915a, content=建议添加表观遗传学的视频,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23991655772, createdName=才华华, createdTime=Mon Oct 12 21:08:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903053, encodeId=48841903053e5, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Sep 01 22:42:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930388, encodeId=88151930388e0, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Aug 26 01:42:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312259, encodeId=73a0131225932, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1313174, encodeId=51a113131e40f, content=<a href='/topic/show?id=64dd9996046' target=_blank style='color:#2F92EE;'>#靶基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99960, encryptionId=64dd9996046, topicName=靶基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584332, encodeId=5cfa15843320c, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=)]
    2014-01-12 chengjn
  6. [GetPortalCommentsPageByObjectIdResponse(id=38791, encodeId=6cf438e915a, content=建议添加表观遗传学的视频,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23991655772, createdName=才华华, createdTime=Mon Oct 12 21:08:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1903053, encodeId=48841903053e5, content=<a href='/topic/show?id=e1b0583884b' target=_blank style='color:#2F92EE;'>#新方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58388, encryptionId=e1b0583884b, topicName=新方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Mon Sep 01 22:42:00 CST 2014, time=2014-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930388, encodeId=88151930388e0, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Aug 26 01:42:00 CST 2014, time=2014-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312259, encodeId=73a0131225932, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1313174, encodeId=51a113131e40f, content=<a href='/topic/show?id=64dd9996046' target=_blank style='color:#2F92EE;'>#靶基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99960, encryptionId=64dd9996046, topicName=靶基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584332, encodeId=5cfa15843320c, content=<a href='/topic/show?id=9bbee5948f0' target=_blank style='color:#2F92EE;'>#筛选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75948, encryptionId=9bbee5948f0, topicName=筛选)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39da17047364, createdName=ms6747015003810650, createdTime=Sun Jan 12 08:42:00 CST 2014, time=2014-01-12, status=1, ipAttribution=)]